Ikena Oncology, Inc. (IKNA)
NASDAQ: IKNA · Real-Time Price · USD
1.710
-0.020 (-1.16%)
Nov 22, 2024, 4:00 PM EST - Market closed
Ikena Oncology Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Net Income | -59.6 | -68.17 | -68.77 | -34.12 | -44.26 | -16.82 | |
Depreciation & Amortization | 0.71 | 1.02 | 0.75 | 0.54 | 0.3 | 0.24 | |
Loss (Gain) From Sale of Assets | 0.84 | 0.01 | 0.17 | - | - | - | |
Asset Writedown & Restructuring Costs | 1.74 | 1.74 | - | - | 11.14 | - | |
Loss (Gain) From Sale of Investments | -1.5 | -2.02 | 0.06 | - | - | - | |
Stock-Based Compensation | 6.05 | 7.63 | 7.53 | 5.18 | 1.8 | 1.17 | |
Other Operating Activities | 2.09 | 1.71 | 1.28 | 1.17 | 0.96 | -0.12 | |
Change in Accounts Payable | -2.41 | -2.87 | -0.29 | 0.36 | 0.52 | -1.33 | |
Change in Unearned Revenue | -0.66 | -9.16 | -15.62 | -30.99 | -9.19 | 64.96 | |
Change in Other Net Operating Assets | -8.83 | -9.64 | 0.77 | -2.41 | 0.9 | -0.17 | |
Operating Cash Flow | -61.56 | -79.74 | -74.11 | -60.25 | -37.83 | 47.93 | |
Capital Expenditures | -0.26 | -0.41 | -1.43 | -1.76 | -0.77 | -0.32 | |
Cash Acquisitions | - | - | - | - | 3.69 | - | |
Investment in Securities | -15.16 | 64.56 | -97.85 | - | - | - | |
Investing Cash Flow | -14.99 | 64.14 | -99.28 | -1.76 | 2.92 | -0.32 | |
Issuance of Common Stock | - | 37.56 | 1.1 | 131.88 | 0.07 | 0.03 | |
Repurchase of Common Stock | - | -0.66 | - | - | - | - | |
Other Financing Activities | 0.06 | 39.09 | - | - | -0.06 | - | |
Financing Cash Flow | 0.06 | 75.98 | 1.1 | 131.74 | 116.18 | 16.32 | |
Net Cash Flow | -76.49 | 60.38 | -172.3 | 69.73 | 81.28 | 63.93 | |
Free Cash Flow | -61.83 | -80.16 | -75.54 | -62.01 | -38.59 | 47.61 | |
Free Cash Flow Margin | -9381.64% | -875.08% | -483.67% | -200.14% | -419.75% | 346.19% | |
Free Cash Flow Per Share | -1.28 | -1.92 | -2.09 | -2.22 | -13.95 | 17.98 | |
Levered Free Cash Flow | -43.97 | -47.98 | -41.98 | -21 | -23 | 8.71 | |
Unlevered Free Cash Flow | -43.97 | -47.98 | -41.98 | -21 | -23 | 8.71 | |
Change in Net Working Capital | 10.28 | 9.08 | 4.51 | 3.63 | -3.49 | -19.18 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.